Biofrontera Inc. has submitted a supplemental New Drug Application to the FDA seeking approval to expand the use of its Ameluz® red light photodynamic therapy (PDT) from treating actinic keratoses (AKs) on the face and scalp to include mild-to-moderate AKs on the extremities, neck, and trunk. This expansion would make Ameluz® the only FDA-approved PDT treatment for AKs on the full body if approved. The submission is supported by positive Phase 3 trial results showing significant clearance of AK lesions and favorable cosmetic outcomes. Approval would allow dermatologists to treat a broader range of patients using the same product and equipment, potentially accelerating Biofrontera's revenue growth.
Biofrontera's supplemental New Drug Application to the FDA aims to expand Ameluz® red light PDT treatment to actinic keratoses on the full body. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 08, 2026 19:42 WIB: out of 128 priced health-sector US stocks, 34 rose and 88 fell. Notable movers include ABEO at USD 5.18 with 100% buy order activity, NVAX at USD 11.00 with 79% sell order activity, and ALNY at USD 220.02 with 92% sell order activity.
CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...
As of September 30, 2026, Societe Generale's share capital consists of 739,264,232 shares with a total of 821,169,560 voting rights. The bank highlights its strong global presence with 110,000 employees serving 27 million clients across 58 countries....
Weyerhaeuser's stock recently dropped to a new 52-week low of $18.31, trading around $18.51, reflecting market pressure. Analysts have mixed views: Seaport Global lowered its price target to $30, Raymond James upgraded to "strong buy" with the same t...
Canadian Utilities and Emera have agreed to merge as equals, creating a larger utility and energy infrastructure company. RBC Capital maintains a 'Sector Perform' rating on Canadian Utilities, indicating expected performance in line with the sector. ...
Domino's Pizza is set to report its Q3 earnings on October 13, 2026, with analysts forecasting earnings per share between $4.33 and $4.36 and revenue around $1.17 billion, a 1.6% increase year-over-year. Investors will watch closely how promotional d...
